Clinical Trial Update: Efficacy of PegIntron and Rebetol in Previously Untreated Patients With Chronic Hepatitis C Infected With HCV Genotype 1/4/5/6 (Study P04243)

View source ↗

Summary

This completed trial evaluated the efficacy of PegIntron (pegylated interferon alfa-2b) plus Rebetol (ribavirin) in treatment-naïve patients with chronic hepati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• PegIntron (pegylated interferon alfa-2b)
• Rebetol (ribavirin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C, Chronic | Status: COMPLETED | Results posted: 2011-01-10